Mar 22, 2022 / 01:00PM GMT
Brett Fishbin - KeyBanc Capital Markets Inc. - Analyst
All right. I'd like to welcome everyone to the first day of the KeyBanc Life Sciences & MedTech Investor Forum. My name is Brett Fishbin, associate analyst. And I'm pleased to be joined by Evolent Health, who's represented today by John Johnson, CFO; and Seth Frank, VP of Investor Relations.
For the audience, I'll start us off. You can submit questions directly to me by typing into the box below the video screen, and I can relay to management. And with that, I'll hand it off for a quick three- to five-minute introduction.
John Johnson - Evolent Health, Inc. - CFO
Thanks, Brett. Good morning, everybody. Thanks for joining us. I'm John Johnson, the Chief Financial Officer of Evolent Health. And Seth Frank is here with me as our Head of IR. For those unfamiliar with Evolent Health, we are a leader in value-based care founded in 2011, went public in 2015. And we have a particular orientation in the broad value-based care world, which is to deliver solutions to risk-bearing entities, mostly health
Evolent Health Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot